1 recruiting, 1 terminated, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
Follow T Cell Non-Hodgkin Lymphoma: new trials by email Literature Review of T Cell Non-Hodgkin Lymphoma trials Research Report on T Cell Non-Hodgkin Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL) Senza5 CART5 - T Cell Non-Hodgkin Lymphoma | Phase 1 | Recruiting | Vittoria Biotherapeutics | 30 | 2024-10-04 | 2025-11-10 |
| Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies Malignancies Fludarabine + Cyclophosphamide + CAR7-T Cells - T-Cell Lymphocytic Leukemia, T-Cell Chronic Lymphocytic Leukemia | Phase 1 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 24 | 2021-04-15 | 2022-03-16 |
| Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma AUTO4 - T Cell Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified | Phase 1 / Phase 2 | Terminated | Autolus Limited | 20 | 2018-08-30 | 2026-03-16 |
Lymphoma, T-Cell (3) · Immunoblastic Lymphadenopathy (1) · Leukemia, Prolymphocytic, T-Cell (1) · Leukemia, T-Cell (1) · Lymphoma (1) · Lymphoma, Large-Cell, Anaplastic (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoma, Non-Hodgkin (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Lymphoma (2) · Hematologic Diseases (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Leukemia, Prolymphocytic (1) · Lymphadenopathy (1)
Cyclophosphamide (1) · fludarabine (1)
Autolus Limited (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · Vittoria Biotherapeutics (1)
China (1) · Spain (1) · United Kingdom (1) · United States (1)
Heng Mei (1)
2017 (1)